Enhancement of Chemical Hepatocarcinogenesis by the HIV-1 tat Gene
- 31 October 2000
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 157 (4), 1081-1089
- https://doi.org/10.1016/s0002-9440(10)64622-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Morphological, Histochemical, Immunohistochemical, and Ultrastructural Characterization of Tumors and Dysplastic and Non-Neoplastic Lesions Arising in BK Virus/tat Transgenic MiceThe American Journal of Pathology, 1999
- A transgenic mouse model for mammary carcinogenesisOncogene, 1998
- HIV Type 1 Extracellular Tat Protein Stimulates Growth and Protects Cells of BK Virus/tatTransgenic Mice from ApoptosisAIDS Research and Human Retroviruses, 1995
- Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcomaNature, 1994
- The expression of the interleukin 6 gene is induced by the human immunodeficiency virus 1 TAT protein.The Journal of Experimental Medicine, 1994
- Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumorsCell, 1993
- Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patientsNature, 1990
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988
- The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic miceNature, 1988
- Effect of a single treatment with the alkylating carcinogens dimethylnitrosamine, diethylnitrosamine and methyl methanesulphonate, on liver regenerating after partial hepatectomy: I. test for induction of liver carcinomasChemico-Biological Interactions, 1975